Trial Profile

A second clinical study in healthy volunteers investigating Micropump sodium oxybate

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 05 Mar 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sodium oxybate (Primary)
Indications Narcolepsy
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

02 Mar 2021 According to an Avadel Pharmaceuticals media release, data from this trial has been published in Clinical Therapeutics.
18 Sep 2019 According to an Avadel Pharmaceuticals media release, data will be presented at the World Sleep 2019 Congress, which is taking place from September 20-25, 2019 at the Vancouver Convention Centre, Vancouver, Canada.
03 Jan 2017 This trial was planned by Flamel Technologies. The company has completed cross-border merger and became Avadel Pharmaceuticals plc, according to a Flamel Technologies media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com